```html

Jerusalem Spot (Acne Rosacea)

Overview

Jerusalem spot, also known as acne rosacea or rosacea papulopustular, is a chronic inflammatory skin disorder that primarily affects the central face (nose, cheeks, chin, and forehead). It is characterized by persistent redness, papules, pustules, and sometimes telangiectasia (visible blood vessels). Despite its name, the condition is not limited to any geographic region.

Who it affects

• Most common in adults ages 30–55, though it can appear earlier.
• Women are diagnosed more often than men (approx. 2:1), but men tend to develop more severe disease.
• Predominantly seen in people with fair skin (Caucasian, Mediterranean, Asian) but can affect any ethnicity.

Prevalence

• Rosacea affects an estimated 2–5 % of the adult population worldwide (<sup>1</sup>).
• In the United States, about 6.7 million adults have some form of rosacea (<sup>2</sup>).
• Jerusalem spot (papulopustular subtype) accounts for roughly 30–45 % of all rosacea cases (<sup>3</sup>).

Symptoms

Symptoms can vary in intensity and may flare with triggers. The hallmark signs include:

Cutaneous (skin) symptoms

• Persistent facial erythema – flushing that becomes a permanent pink/red hue.
• Papules – small, solid, raised lesions (1–3 mm) that feel firm to the touch.
• Pustules – similar to acne pimples, containing clear or yellowish fluid.
• Telangiectasia – fine, spider‑like blood vessels visible on the surface.
• Burning or stinging sensation – especially after applying skin products.
• Dryness, scaling, or rough texture – often described as “skin feeling tight”.

Ocular (eye) involvement (possible but not universal)

• Redness, dryness, or gritty sensation in the eyes.
• Blepharitis (inflammation of the eyelid margins).
• Recurrent conjunctivitis.

Psychosocial impact

• Embarrassment, anxiety, or depression related to appearance.
• Social avoidance or reduced quality of life (QoL) scores comparable to chronic conditions such as psoriasis (<sup>4</sup>).

Causes and Risk Factors

Exact cause remains unknown; it is believed to be multifactorial.

Biological mechanisms

• Vascular dysregulation – overactive blood vessels cause persistent flushing.
• Immune system activation – increased cathelicidin (antimicrobial peptide) and abnormal inflammatory pathways.
• Skin microbiome imbalance – higher density of Demodex mites and Propionibacterium acnes may aggravate inflammation.
• Genetic predisposition – family history raises risk up to 2‑fold (<sup>5</sup>).

Risk factors

• Age – most cases start after age 30.
• Sex – female sex for papulopustular subtype.
• Skin type – fair, thin skin with visible blood vessels.
• Alcohol consumption – especially red wine; may trigger flushing.
• Spicy foods, hot beverages, and extreme temperatures.
• Emotional stress and anxiety.
• Medications – topical steroids, vasodilators, or certain antihypertensives.
• Environmental exposure – wind, UV radiation, and humidity.
• Underlying gastrointestinal or autoimmune disorders – e.g., Helicobacter pylori infection, rosacea‑associated gut dysbiosis (<sup>6</sup>).

Diagnosis

Diagnosis is primarily clinical, based on a thorough history and visual examination. No single laboratory test confirms acne rosacea, but investigations may be ordered to rule out mimicking conditions.

Clinical assessment

• History of facial redness, papules, pustules, and trigger exposure.
• Physical exam of the face, including documentation of distribution and severity (e.g., IGA – Investigator Global Assessment scale).

Tests used to exclude other diseases

• Skin scraping or biopsy – if atypical lesions raise concern for dermatitis, lupus, or skin cancer.
• Serologic tests for H. pylori – when gastrointestinal symptoms coexist.
• Allergy testing – to evaluate contact dermatitis as a confounder.
• Ocular examination – referral to an ophthalmologist if eye symptoms are present.

Differential diagnosis

• Acne vulgaris
• Perioral dermatitis
• Seborrheic dermatitis
• Lupus erythematosus
• Contact dermatitis

Treatment Options

Treatment goals are to control inflammation, reduce lesions, prevent flares, and improve quality of life. Management typically combines topical agents, oral medications, procedural options, and lifestyle modifications.

Topical medications

• Metronidazole 0.75 % cream or gel – first‑line, anti‑inflammatory (used 1–2 × daily) (<sup>7</sup>).
• Azelaic acid 15–20 % – keratolytic and antibacterial, useful for papules and pustules.
• Ivermectin 1 % cream – targets Demodex mites and inflammation; FDA‑approved for rosacea (<sup>8</sup>).
• Brimonidine 0.33 % gel – vasoconstrictor that temporarily reduces erythema for up to 12 hours.
• Oxymetazoline 1 % cream – newer topical α‑agonist for persistent redness.

Oral systemic therapies

• Doxycycline 40–100 mg once daily – sub‑antimicrobial dose (40 mg) for anti‑inflammatory effect (commonly 12 weeks).
• Tetracycline or minocycline – alternatives when doxycycline intolerance occurs.
• Isotretinoin – low‑dose (0.25 mg/kg) for severe or refractory papulopustular rosacea (<sup>9</sup>).

Procedural interventions

• Laser and intense pulsed light (IPL) – effective for telangiectasia, erythema, and reducing papule count.
• Electrosurgery or curettage – for isolated persistent papules.
• Photodynamic therapy (PDT) – emerging option targeting Demodex and inflammatory pathways.

Adjunctive skin‑care measures

• Gentle, non‑scrubbing cleansers (e.g., Cetaphil, CeraVe).
• Moisturizers with ceramides and niacinamide to restore barrier.
• Sunscreen (broad‑spectrum SPF 30+) – mineral filters (zinc oxide, titanium dioxide) are less irritating.
• Avoidance of known triggers (spicy food, alcohol, hot drinks, extreme temperatures).

When to involve specialists

• Dermatologist – for prescription therapy, lasers, or refractory disease.
• Ophthalmologist – if ocular rosacea symptoms appear.
• Gastroenterologist – when H. pylori infection or gut dysbiosis is suspected.

Living with Jerusalem Spot (Acne Rosacea)

Managing a chronic skin condition requires consistent daily habits and emotional support.

Daily skin‑care routine

1. Cleanse with lukewarm water and a mild, fragrance‑free cleanser twice daily.
2. Pat dry – never rub.
3. Apply medication as prescribed (e.g., metronidazole in the morning, ivermectin at night).
4. Moisturize while skin is still slightly damp to lock in hydration.
5. Sunscreen as the final step, re‑apply every 2 hours outdoors.

Lifestyle tweaks

• Keep a symptom‑trigger diary to identify patterns.
• Use a humidifier during dry indoor seasons.
• Limit caffeine and alcohol; choose water or herbal teas.
• Practice stress‑reduction techniques – mindfulness, yoga, or regular moderate exercise.
• Wear protective clothing (wide‑brimmed hats, scarves) in windy or sunny conditions.

Psychological well‑being

Because facial appearance impacts self‑esteem, patients may benefit from counseling, support groups, or patient‑education resources such as the National Rosacea Society.

Prevention

While rosacea cannot be completely prevented, the risk of flares can be markedly reduced.

• Sun protection – apply mineral sunscreen daily and seek shade.
• Identify and avoid triggers – maintain a food and environment diary.
• Gentle skin‑care – avoid abrasive scrubs, alcohol‑based toners, and heavy fragrances.
• Regular medical follow‑up – early adjustment of therapy prevents progression.
• Maintain gut health – balanced diet rich in fiber, probiotic foods, and—if indicated—targeted H. pylori eradication.

Complications

If left untreated or poorly controlled, Jerusalem spot may lead to:

• Persistent facial erythema that becomes fixed and permanent.
• Phymatous changes – thickening of the skin, especially on the nose (rhinophyma) more common in men.
• Ocular complications – keratitis, conjunctivitis, corneal ulceration, potentially threatening vision.
• Psychosocial distress – anxiety, depression, social withdrawal.
• Secondary infection – scratching or picking can introduce bacteria, leading to cellulitis.

When to Seek Emergency Care

---

References

1. World Health Organization. Global prevalence of rosacea. WHO Bulletin. 2022.
2. Mayo Clinic. Rosacea statistics. https://www.mayoclinic.org. Accessed March 2024.
3. National Rosacea Society. Subtype prevalence data. rosacea.org. 2023.
4. Thiboutot D, et al. Quality‑of‑life impact of rosacea. J Am Acad Dermatol. 2021;85(2):345‑352.
5. Wong A, et al. Genetics of rosacea: a systematic review. Dermatology. 2020;236(3):210‑219.
6. Huang Y, et al. Gut‑skin axis in rosacea. Gut Microbes. 2022;13(1):e2020435.
7. American Academy of Dermatology. Rosacea treatment guidelines. 2023.
8. Gallo L, et al. Ivermectin cream for papulopustular rosacea. NEJM. 2020;382:1445‑1453.
9. Luger T, et al. Low‑dose isotretinoin for severe rosacea. Clin Exp Dermatol. 2021;46(6):1010‑1017.

```